Search clinical trials for: talabostat mesylate
Total 1650 results
-
BioXcel Therapeutics IncIQVIA BiotechWithdrawnPancreatic Cancer | Pancreas Cancer | Cancer of Pancreas | Cancer of the Pancreas | Neoplasms, PancreaticUnited States
-
Eric Stephen Winer, MDRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2United States
-
Point TherapeuticsTerminatedCarcinoma, Non-Small Cell LungUnited States
-
Point TherapeuticsCompleted
-
Point TherapeuticsCompletedChronic Lymphocytic LeukemiaUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedSarcoma | Kidney Cancer | Unspecified Childhood Solid Tumor, Protocol Specific | Ovarian Cancer | Brain and Central Nervous System Tumors | Neuroblastoma | Liver Cancer | Childhood Germ Cell TumorUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAdvanced Malignant Solid Neoplasm | Recurrent Malignant Solid NeoplasmUnited States
-
Eisai LimitedCompleted
-
Point TherapeuticsCompleted
-
Point TherapeuticsTerminatedAdenocarcinoma | Neoplasm Metastasis | Pancreatic CancerUnited States
-
University of NebraskaNational Cancer Institute (NCI)Withdrawn
-
Chengdu Zenitar Biomedical Technology Co., LtdCompletedDiffuse Large B Cell Lymphoma，DLBCLChina
-
University of BolognaCompletedMyeloid Leukemia, Chronic, Chronic-PhaseItaly
-
Novartis PharmaceuticalsCompletedRefractory Desmoplastic Small Round Cell TumorsItaly
-
IlDong Pharmaceutical Co LtdCompletedHealthyKorea, Republic of
-
Point TherapeuticsCompleted
-
Nanjing First Hospital, Nanjing Medical UniversityEnrolling by invitationMain Heading (Descriptor) TermsChina
-
Eisai LimitedCompletedAdvanced Solid TumorFrance
-
Eisai Inc.Completed
-
Eisai Co., Ltd.Completed
-
Calgent Biotechnology Co., LtdCompletedResistant or Refractory Solid TumorsUnited States, Taiwan
-
Eisai Korea Inc.CompletedBreast Cancer | Breast NeoplasmsKorea, Republic of
-
Eisai Inc.Approved for marketingMetastatic Breast CancerCanada, Belgium, France
-
Merz Pharmaceuticals GmbHTerminatedSubjective TinnitusUnited States, United Kingdom, Poland, Austria, Belgium, Brazil, Czech Republic, France, Germany, Mexico, Netherlands, Portugal, South Africa, Spain
-
Pathway Therapeutics, Inc.Completed
-
Merz Pharmaceuticals GmbHTerminatedMultiple Sclerosis | Nystagmus, Congenital | Nystagmus, AcquiredUnited Kingdom
-
Merz Pharmaceuticals GmbHCompleted
-
Centre Leon BerardCompletedGastrointestinal Stromal Tumors | Resected Gastrointestinal Stromal Tumors | Non-metastatic | High Risk of Recurrence | KIT Gene MutationFrance
-
The First Affiliated Hospital with Nanjing Medical...Not yet recruitingTriple Negative Breast CancerChina
-
National Cancer Institute (NCI)CompletedHead and Neck CancerUnited States
-
Merz Pharmaceuticals GmbHCompletedSubjective TinnitusUnited States, Austria, Germany, Brazil, Mexico
-
Merz Pharmaceuticals GmbHCompletedSubjective TinnitusBelgium, Czech Republic, France, Poland, South Africa, Netherlands
-
Cancer Institute and Hospital, Chinese Academy...RecruitingTriple Negative Breast CancerChina
-
Eisai Inc.Completed
-
Eisai Inc.Children's Oncology GroupCompleted
-
Chang Gung Memorial HospitalEisai Co., Ltd.; Kaohsiung Breast Cancer Prevention and Education Society (KBCPES)UnknownAdvanced Breast Cancer | Metastatic Breast CancerTaiwan
-
Eisai Co., Ltd.Completed
-
Merz Pharmaceuticals GmbHCompletedSubjective TinnitusGermany, Portugal, Spain, United Kingdom, Austria
-
Eisai Inc.Completed
-
Hunan Cancer HospitalCompletedMetastatic Breast CancerChina
-
Oncologia Medica dell'Ospedale FatebenefratelliMario Negri Institute for Pharmacological ResearchCompletedMetastatic Breast Cancer | Toxicity | Neurotoxicity | Adverse Drug Event | Drug ToxicityItaly
-
Seoul National University HospitalRecruitingAdvanced Breast CancerKorea, Republic of
-
InteKrin Therapeutics, Inc.CompletedDiabetes Mellitus, Type IIUnited States
-
Cancer Research UKLatus TherapeuticsTerminatedCOVID-19 InfectionUnited Kingdom
-
CelgeneCompletedHepatic ImpairmentUnited States
-
CelgeneCompletedHepatic ImpairmentUnited States
-
Point TherapeuticsTerminatedCarcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Neoplasms, PulmonaryUnited States
-
Zhejiang Cancer HospitalNot yet recruiting
-
UConn HealthNational Institute on Aging (NIA); University of ConnecticutNot yet recruitingFrailty | Aging | Mild Cognitive ImpairmentUnited States
-
Eisai Inc.Completed